3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Yew Bio-Pharm Group's 3-Year ROIIC % for the quarter that ended in Dec. 2020 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Yew Bio-Pharm Group's 3-Year ROIIC % or its related term are showing as below:
YEWB's 3-Year ROIIC % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 1.77 * Ranked among companies with meaningful 3-Year ROIIC % only.
Yew Bio-Pharm Group 3-Year ROIIC % Historical Data
The historical data trend for Yew Bio-Pharm Group's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Yew Bio-Pharm Group's 3-Year ROIIC %
For the Farm Products subindustry, Yew Bio-Pharm Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yew Bio-Pharm Group's 3-Year ROIIC % Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Yew Bio-Pharm Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Yew Bio-Pharm Group's 3-Year ROIIC % falls into.
Yew Bio-Pharm Group 3-Year ROIIC % Calculation
Yew Bio-Pharm Group's 3-Year ROIIC % for the quarter that ended in Dec. 2020 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 2.4887628 (Dec. 2020) - 3.3240025 (Dec. 2017) )
/
( 57.504 (Dec. 2020) - 50.771 (Dec. 2017) )
=
-0.8352397
/
6.733
=
-12.41%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Yew Bio-Pharm Group (OTCPK:YEWB) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Yew Bio-Pharm Group 3-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Yew Bio-Pharm Group's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description
Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
YEWB has been successfully added to your 